Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 20, 2020
Clinical Outcomes of Stereotactic Body Radiotherapy With Immediate Versus Delayed Hormone Therapy in Men With Oligometastatic Recurrence of Prostate CancerC L Chaw, N M deSouza, V Khoo, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 10, 2021
Metastasis-directed Therapy in Prostate Cancer: Prognostic Significance of the ESTRO/EORTC Classification in Oligometastatic Bone DiseaseL Nicholls, E Chapman, V Khoo, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 22, 2023
Patterns of Failure After Stereotactic Body Radiotherapy to Sacral MetastasesR Ratnakumaran, N van As, V Khoo, et al.
British Journal of Cancer|April 22, 2015
Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladderS Hafeez, A Horwich, O Omar, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 26, 2022
Prostate Volume Changes during Extreme and Moderately Hypofractionated Magnetic Resonance Image-guided RadiotherapyS E Alexander, H A McNair, U Oelfke, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 3, 2016
Pattern of Progression after Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal RecurrencesP Ost, B A Jereczek-Fossa, N Van As, et al.
The British Journal of Radiology|May 20, 2008
Correlation of diffusion-weighted MRI with whole mount radical prostatectomy specimensN Van As, E Charles-Edwards, A Jackson, et al.
International Journal of Clinical Practice|October 7, 2014
Development of UK guidance on the management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancerI D White, J Wilson, P Aslet, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 28, 2015
Initial UK Experience of Stereotactic Body Radiotherapy for Extracranial Oligometastases: Can We Change the Therapeutic Paradigm?K Aitken, A Tree, K Thomas, et al.
British Journal of Cancer|August 10, 2013
Antitumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancerA Omlin, C J Pezaro, S Zaidi, et al.
Pageof 2